Variant report
Variant | nsv438062 |
---|---|
Chromosome Location | chr8:65115877-65117805 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3912470 | chr8:65115877-65115878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs141176346 | chr8:65115920-65115921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150901800 | chr8:65115968-65115969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs936793 | chr8:65116000-65116001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs556543400 | chr8:65116042-65116043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs936794 | chr8:65116073-65116074 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs190950507 | chr8:65116114-65116115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183400836 | chr8:65116115-65116116 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369859816 | chr8:65116225-65116226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531790725 | chr8:65116226-65116227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs3896750 | chr8:65116231-65116232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187294387 | chr8:65116265-65116266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553186070 | chr8:65116274-65116275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564680503 | chr8:65116312-65116313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532231576 | chr8:65116328-65116329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs547106902 | chr8:65116379-65116380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs369222609 | chr8:65116389-65116390 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372085026 | chr8:65116395-65116396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565656519 | chr8:65116425-65116426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539724150 | chr8:65116441-65116442 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1485491 | chr8:65116458-65116459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535660452 | chr8:65116473-65116474 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs139388453 | chr8:65116491-65116492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75568616 | chr8:65116496-65116497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs1485492 | chr8:65116547-65116548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs116285144 | chr8:65116565-65116566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537281064 | chr8:65116597-65116598 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs190684616 | chr8:65116620-65116621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs534750881 | chr8:65116623-65116624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs557738387 | chr8:65116674-65116675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150061885 | chr8:65116675-65116676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370024665 | chr8:65116761-65116762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs539106027 | chr8:65116802-65116803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs553939918 | chr8:65116830-65116831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183239188 | chr8:65116879-65116880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs5891945 | chr8:65116894-65116895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542608107 | chr8:65116937-65116938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558476647 | chr8:65116954-65116955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554852447 | chr8:65116976-65116977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576319228 | chr8:65116977-65116978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188021820 | chr8:65116992-65116993 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs565116111 | chr8:65116993-65116994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs377555795 | chr8:65117048-65117049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577720409 | chr8:65117061-65117062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs35240798 | chr8:65117082-65117083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532143754 | chr8:65117088-65117089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs541137931 | chr8:65117097-65117098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs369563457 | chr8:65117115-65117116 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs546484833 | chr8:65117140-65117141 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559157784 | chr8:65117150-65117151 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:65107400-65116800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr8:65116800-65117000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:65116800-65117400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr8:65117000-65119400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr8:65117400-65118400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |